“IP rights are usually the true asset that a start-up company has.” Dr. Philipp Marchand talks with BaseLaunch and takes some questions from an audience…
Mariela Salas28.07.2020
After more than 25 years in the pharma business, Andreas Katopodis founded the biotech company Anaveon together with Professor Onur Boyman. In 2019, the startup…
Jérémie Meyer06.12.2019
“We make no compromises in creating the highest potential company” Versant Ventures has a strong history in building successful companies such as Therachon, Black Diamond…
Jérémie Meyer30.07.2019
Regeneron Pharmaceuticals is one of the biggest biotech success stories. It’s the first biotech in history with 6 marketed drugs, all originated from its own…
Jérémie Meyer30.07.2019
ARCH Venture Partners is behind companies such as Illumina, Alnylam, Unity Biotechnology, Receptos, Agios Pharmaceuticals, Grail, Bluebird, and many more. This interview is part of…
Jérémie Meyer24.05.2019
“We are a small company with a big portfolio” After Martine and Jean-Paul Clozel created Actelion with two other founders and grew Actelion into Europe’s…
Jérémie Meyer22.01.2019
Herbert Reutimann, the CEO of Unitectra, the joint technology transfer organization of the Universities of Basel, Bern and Zurich, talks about the ways in which…
Jérémie Meyer11.12.2018
Giacomo di Nepi has a successful history: A high level executive in big corporations, he transitioned towards biotech, currently as CEO of Polyphor, which, in…
Jérémie Meyer10.09.2018
